HIV Programs in Iran (Persia), Iraq and Saudi Arabia: A Brief Review of Current Evidence in West and Southwest Asia

Omid Massah, Afsaneh Moradi, Ali Farhoudian, Mahmood Amini-Lari, Hassan Joulaei, Reza Daneshmand

Abstract


Background: In Western and Southwest Asia, literature is not documented on human immunodeficiency virus (HIV) programs in Iran, Iraq and Saudi Arabia. The present study is the first brief review that describes HIV programs in these three neighboring countries.

Methods: Data regarding the evidence of HIV programs were gathered through a systematic literature searching. English publications were retrieved through searching online scientific databases. Grey literature was also searched online. The review was based on the studies related to the last decade.

Findings: Systematic searching resulted in retrieving 21,948 studies but only 21 studies were relevant to the study aim. The review findings indicated that Iran has provided a nationwide sero-surveillance data system and has identified its key populations. Detecting HIV prevalence has been limited to case-finding in Iraq and Saudi Arabia. However, strategic plans for HIV have been provided in the three countries. HIV education, knowledge and support have been provided but still needs consideration in the three countries especially in Iraq. The low coverage of antiretroviral therapy (ART) has remained a critical gap in the provision of comprehensive HIV programs in these three countries. This issue has been followed by the lack of opiate substitution therapies for drug dependents and injecting drug users in Iraq and Saudi Arabia. Condom promotion and voluntary HIV counselling and testing have been provided for at-risk groups in the three countries but need more nationwide coverages. However, needle and syringe programs (NSPs) have been only provided in Iran.

Conclusion: The review concluded that the provision of effective HIV programs should address training human resources and infrastructural development. This issue should be facilitated by international collaborations and governmental supports.

Keywords


HIV; Iran; Iraq; Saudi Arabia; Persian Gulf

Full Text:

PDF

References


Kassebaum NJ, Bertozzi-Villa A, Coggeshall MS, Shackelford KA, Steiner C, Heuton KR, et al. Global, regional, and national levels and causes of maternal mortality during 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014; 384(9947): 980-1004.

Murray CJ, Ortblad KF, Guinovart C, Lim SS, Wolock TM, Roberts DA, et al. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014; 384(9947): 1005-70.

Mumtaz GR, Weiss HA, Thomas SL, Riome S, Setayesh H, Riedner G, et al. HIV among people who inject drugs in the Middle East and North Africa: systematic review and data synthesis. PLoS Med 2014; 11(6): e1001663.

Moradi G, Mohraz M, Gouya MM, Dejman M, Seyedalinaghi S, Khoshravesh S, et al. Health needs of people living with HIV/AIDS: From the perspective of policy makers, physicians and consultants, and people living with HIV/AIDS. Iran J Public Health 2014; 43(10): 1424-35.

Ministry of Health in Iraq. Global AIDS response progress report of Iraq [Online]. [cited 2012]; Available from: URL: www.unaids.org/sites/ce_IQ_Narrative_Report%5B1%5D.pdf

Rahimi-Movaghar A, Amin-Esmaeili M, Aaraj E, Hermez J. Assessment of situation and response of drug use and its harm in the Middle East and North Africa. Beirut, Lebanon: Middle East and North Africa Harm Reduction Association; 2012.

Moayedi-Nia S, Bayat JZ, Esmaeeli Djavid G, Entekhabi F, Bayanolhagh S, Saatian M, et al. HIV, HCV, HBV, HSV, and syphilis prevalence among female sex workers in Tehran, Iran, by using respondent-driven sampling. AIDS Care 2016; 28(4): 487-90.

Alzahrani M, Hull MC, Sherlock C, Griswold D, Leger CS, Leitch HA. Human immunodeficiency virus-associated multicentric Castleman disease refractory to antiretroviral therapy: clinical features, treatment and outcome. Leuk Lymphoma 2015; 56(5): 1246-51.

World Population Review. Iran Population [Online]. [cited 2016]; Available from: URL: http://worldpopulationreview.com/countries/iran-population

Ministry of Health and Medical Education in Iran. Global AIDS response progress report of Iran. [Online]. [cited 2014]; Available from: URL: http://files.unaids.org/en/knowyourresponse/countryprogressreports/2014countries/IRN_narrative_report_2014_en.pdf

World Population Review. Iraq Population [Online]. [cited 2016]; Available from: URL: http://worldpopulationreview.com/countries/iraq-population/

Al-Kubaisy WA, Al-Naib KT, Habib MA. Prevalence of HCV/HIV co-infection among haemophilia patients in Baghdad. East Mediterr Health J 2006; 12(3-4): 264-9.

Yanni EA, Naoum M, Odeh N, Han P, Coleman M, Burke H. The health profile and chronic diseases comorbidities of US-bound Iraqi refugees screened by the International Organization for Migration in Jordan: 2007-2009. J Immigr Minor Health 2013; 15(1): 1-9.

World Population Review. Saudi Arabia Population [Online]. [cited 2016]; Available from: URL: http://worldpopulationreview.com/countries/saudi-arabia-population/

Ministry of Health in Saudi Arabia. Global AIDS response progress report of Saudi Arabia [Online]. [cited 2014]; Available from: URL: www.unaids.org/knowyourresponse/countryprogress reports/2014countries

Memish ZA, Almasri M, Chentoufi AA, Al-Tawfiq JA, Al-Shangiti AM, Al-Kabbani KM, et al. Seroprevalence of Herpes Simplex Virus Type 1 and Type 2 and Coinfection With HIV and Syphilis: The First National Seroprevalence Survey in Saudi Arabia. Sex Transm Dis 2015; 42(9): 526-32.

Al-Mozaini MA, Mansour MK, Al-Hokail AA, Mohmed MA, Daham MA, Al-Abdely HM, et al. HIV-Care Outcome in Saudi Arabia; a Longitudinal Cohort. J AIDS Clin Res 2014; 5(11).

Filemban SM, Yasein YA, Abdalla MH, Al-Hakeem R, Al-Tawfiq JA, Memish ZA. Prevalence and behavioral risk factors for STIs/HIV among attendees of the Ministry of Health hospitals in Saudi Arabia. J Infect Dev Ctries 2015; 9(4): 402-8.

Bassiony M. Substance use disorders in Saudi Arabia: Review article. J Subst Use 2013; 18(6): 450-66.

United Nations Development Program. Procurement notice and request for proposal for provision of technical support to improve HIV prevention, treatment and care under HIV/AIDS new funding model (NFM) [Project]. Tehran, Iran: UNDP; 2015.

Moradi G, Farnia M, Shokoohi M, Shahbazi M, Moazen B, Rahmani K. Methadone maintenance treatment program in prisons from the perspective of medical and non-medical prison staff: a qualitative study in Iran. Int J Health Policy Manag 2015; 4(9): 583-9.

Siziya S, Muula AS, Rudatsikira E. HIV and AIDS-related knowledge among women in Iraq. BMC Res Notes 2008; 1: 123.

Othman SM. Knowledge about HIV/AIDS among high school students in Erbil city/Iraq. Glob J Health Sci 2015; 7(1): 16-23.

Hayyawi AH, Al-Marayaty AY, Salman WS, Hamed W. HIV/AIDS knowledge, attitudes and beliefs among a group of Iraqis. East Mediterr Health J 2010; 16(1): 18-23.

Ismael AS, Sabir Zangana JM. Knowledge, attitudes and practice of condom use among males aged (15-49) years in Erbil Governorate. Glob J Health Sci 2012; 4(4): 27-36.

Memish ZA, Al-Tawfiq JA, Filemban SM, Qutb S, Fodail A, Ali B, et al. Antiretroviral therapy, CD4, viral load, and disease stage in HIV patients in Saudi Arabia: a 2001-2013 cross-sectional study. J Infect Dev Ctries 2015; 9(7): 765-9.

Alam-Mehrjerdi Z, Abdollahi M, Higgs P, Dolan K. Drug use treatment and harm reduction programs in Iran: A unique model of health in the most populated Persian Gulf country. Asian J Psychiatr 2015; 16: 78-83.

Karamouzian M, Haghdoost AA, Sharifi H. Addressing the needs of sexual partners of people who inject drugs through peer prevention programs in Iran. Int J Health Policy Manag 2014; 2(2): 81-3.

Shahbazi M, Farnia M, Moradi G, Karamati M, Paknazar F, Mirmohammad Khani M. Injecting Drug Users Retention in Needle-Exchange Program and its Determinants in Iran Prisons. Int J High Risk Behav Addict 2015; 4(2): e23751.

Shahbazi M, Farnia M, Keramati M, Alasvand R. Advocacy and piloting the first needle and syringe exchange program in Iranian prisons. Retrovirology 2010; 7(Suppl 1): P81.

Nasirian M, Doroudi F, Gooya MM, Sedaghat A, Haghdoost AA. Modeling of human immunodeficiency virus modes of transmission in Iran. J Res Health Sci 2012; 12(2): 81-7.

Haghdoost AA, Mostafavi E, Mirzazadeh A, Navadeh S, Feizzadeh A, Fahimfar N, et al. Modelling of HIV/AIDS in Iran up to 2014. J AIDS HIV Res 2011; 3(12): 231-9.

Sajadi L, Mirzazadeh A, Navadeh S, Osooli M, Khajehkazemi R, Gouya MM, et al. HIV prevalence and related risk behaviours among female sex workers in Iran: results of the national biobehavioural survey, 2010. Sex Transm Infect 2013; 89(Suppl 3): iii37-iii40.




DOI: http://dx.doi.org/10.22122/ahj.v8i3.405

Refbacks

  • There are currently no refbacks.